NHS patients begin receiving weight loss balloon
The balloon, tucked inside a capsule, is swallowed by the patient and filled with water during a 15-minute visit to a doctor.
Your support helps us to tell the story
This election is still a dead heat, according to most polls. In a fight with such wafer-thin margins, we need reporters on the ground talking to the people Trump and Harris are courting. Your support allows us to keep sending journalists to the story.
The Independent is trusted by 27 million Americans from across the entire political spectrum every month. Unlike many other quality news outlets, we choose not to lock you out of our reporting and analysis with paywalls. But quality journalism must still be paid for.
Help us keep bring these critical stories to light. Your support makes all the difference.
NHS patients have begun receiving a type of weight-loss pill – a capsule that contains a gastric balloon which is filled with water.
The treatment, which can be delivered in 15 minutes, is approved by the National Institute for Health and Care Excellence (Nice) and is designed to make people feel fuller, so they eat less.
Allurion, the company behind the pill, said it has been in talks with NHS trusts about rolling out the treatment since it was approved in 2020.
Now the first two NHS patients have been treated at Musgrove Park Hospital, part of Somerset NHS Foundation Trust.
We are very pleased to be able to offer this new treatment, a first for the NHS, that offers clinically meaningful weight loss as part of a holistic programme involving dietary support and care
The pill differs from some other gastric balloons in that it requires no surgery, endoscopy or anaesthesia to place it.
The balloon, tucked inside a capsule, is swallowed by the patient and filled with water during a 15-minute doctor’s visit.
The patient swallows the capsule which is attached to a thin tube.
An X-ray confirms the correct placement in the stomach and 550ml of water is put into the balloon via the tube.
A second X-ray is then taken to check the balloon is full and sitting well in the stomach. The tube is then removed.
After around four months, a time-activated release valve automatically opens, allowing the water-filled balloon to empty and pass naturally through the gastrointestinal tract.
Data suggests the device helps patients lose an average of 10-15% of their body weight after 16 weeks.
Furthermore, people managed to keep 95% of their weight off for a year after treatment. A nutrition and lifestyle programme is provided by Allurion to help keep people on track.
A further three NHS patients are due to be treated in early February, with up to a dozen others also scheduled.
We are looking forward to expanding this partnership and benefiting many more NHS patients in the months and years to come
Professor Richard Welbourn, consultant bariatric surgeon at Somerset NHS Foundation Trust, said: “We are very pleased to be able to offer this new treatment, a first for the NHS, that offers clinically meaningful weight loss as part of a holistic programme involving dietary support and care.
“People with severe obesity are prone to diseases, such as type 2 diabetes, which can be reversed with weight loss.
“The Allurion balloon is a 15-minute outpatient procedure, and is swallowed, so there’s no need for an endoscopy, hospital bed, theatre time or anaesthetic, which is better for the NHS and a much-improved experience for our patients.
“We expect that patients using the programme will lose 10-15% of their weight in four months, which improves quality of life and makes patients healthier.”
Dr Shantanu Gaur, founder and chief executive of Allurion, said: “We are thrilled to be partnering with the NHS for the first time to deliver the Allurion programme.
“We are looking forward to expanding this partnership and benefiting many more NHS patients in the months and years to come.”
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.